ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,216Medicare Part D Prescriptions Filled, Including Refills

Rank: 316 out of 1107

$396K Total Retail Price of All Prescriptions

Rank: 490 out of 1107

567 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 567 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 567 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 6,148 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 779 288 S3 1 1
SIMVASTATIN 443 268 2 5
FUROSEMIDE 305 230 3 7
OMEPRAZOLE 265 172 4 4
LEVOTHYROXINE SODIUM 257 166 5 3
GABAPENTIN 251 87 6 9
TRAMADOL HCL 210 117 7 26
ENALAPRIL MALEATE 184 131 8 98
AMLODIPINE BESYLATE 181 138 9 6
LISINOPRIL 165 109 10 2
CITALOPRAM HBR 140 86 11 17
MELOXICAM 136 80 12 25
POTASSIUM CHLORIDE 132 118 13 14
AMOXICILLIN 128 75 14 90
HYDROCHLOROTHIAZIDE 127 96 15 11
GLYBURIDE 122 99 R 16 68
TRAZODONE HCL 122 80 16 33
METFORMIN HCL 119 74 18 8
FLUOXETINE HCL 115 66 19 47
NEXIUM 114 30 20 18
ACETAMINOPHEN-CODEINE 114 73 S3 20 120
RANITIDINE HCL 113 77 22 21
TRIAMTERENE-HYDROCHLOROTHIAZID 111 48 23 185
BACLOFEN 109 54 24 133
ATENOLOL 109 88 24 19
METOPROLOL TARTRATE 108 67 26 10
WARFARIN SODIUM 100 57 27 15
ISOSORBIDE MONONITRATE ER 96 84 28 34
SERTRALINE HCL 96 59 28 20
CLOPIDOGREL 94 80 30 28
PROMETHAZINE HCL 94 30 R 30 44
METOPROLOL SUCCINATE 81 61 32 16
ZOLPIDEM TARTRATE 74 23 33 22
PROAIR HFA 70 11 34 37
PREDNISONE 68 50 35 40
PROPRANOLOL HCL 65 44 36 134
AZITHROMYCIN 65 26 36 35
PAROXETINE HCL 62 24 38 45
MECLIZINE HCL 61 51 39 114
CYCLOBENZAPRINE HCL 61 12 R 39 56
POLYETHYLENE GLYCOL 3350 57 30 41 46
DIGOXIN 56 53 42 52
FLUTICASONE PROPIONATE 56 24 42 38
IBUPROFEN 55 32 44 63
CRESTOR 54 30 45 23
KLOR-CON 8 53 39 46 261
ATORVASTATIN CALCIUM 53 39 46 13
CIPROFLOXACIN HCL 51 36 48 59
METHYLPREDNISOLONE 50 37 49 119
ALLOPURINOL 50 33 49 36
AMITRIPTYLINE HCL 50 30 R 49 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.